yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q47118783-574701B5-588E-4FD8-AE16-D34D6E091574
Q47118783-574701B5-588E-4FD8-AE16-D34D6E091574
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47118783-574701B5-588E-4FD8-AE16-D34D6E091574
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab.
P2860
Q47118783-574701B5-588E-4FD8-AE16-D34D6E091574
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47118783-574701B5-588E-4FD8-AE16-D34D6E091574
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32d8a16f0ef5ab5b4e07e06649129ec783fd4739
P2860
Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD